User Tools

Site Tools


respiratory:beta2_agonists:start

Differences

This shows you the differences between two versions of the page.

Link to this comparison view

respiratory:beta2_agonists:start [2026/02/15 15:04] – created andrew2393cnsrespiratory:beta2_agonists:start [2026/02/15 15:05] (current) – removed andrew2393cns
Line 1: Line 1:
-====== Short-Acting β2 Agonists (SABA) ====== 
  
-{{tag>respiratory bronchodilator beta2_agonist saba}} 
- 
-Short-acting β2 agonists are rapid bronchodilators used for immediate relief of bronchospasm. 
- 
-They are the **primary rescue medications** in obstructive lung disease. 
- 
-<WRAP center round important 70%> 
-SABA = symptom relief   
-They do NOT control inflammation 
-</WRAP> 
- 
----- 
- 
-===== Drugs in Class ===== 
- 
-  * [[respiratory:beta2_agonists:albuterol|Albuterol]] 
-  * [[respiratory:beta2_agonists:levalbuterol|Levalbuterol]] 
- 
----- 
- 
-===== Mechanism of Action ===== 
- 
-**Receptor** 
-  * β2 adrenergic receptor activation 
- 
-**Cellular Effect** 
-  * ↑ cAMP 
-  * Smooth muscle relaxation 
- 
-**Physiologic Effects** 
-  * Bronchodilation 
-  * ↓ airway resistance 
-  * ↓ mast cell mediator release 
-  * ↑ mucociliary clearance 
-  * Intracellular potassium shift 
- 
-Net effect: 
-  * Rapid airway opening 
- 
----- 
- 
-===== Clinical Role ===== 
- 
-Primary uses: 
-  * Acute asthma symptoms 
-  * Exercise-induced bronchospasm 
-  * COPD rescue therapy 
- 
-Also used for: 
-  * Hyperkalemia (temporary intracellular shift) 
- 
-SABA should always be paired with controller therapy in persistent asthma: 
-  * [[respiratory:inhaled_corticosteroids:start|Inhaled Corticosteroids]] 
- 
----- 
- 
-===== Dosing Concept ===== 
- 
-<WRAP center 70%> 
-^ Situation ^ Meaning ^ 
-| Rare use | Controlled disease | 
-| >2 days/week | Inadequate control | 
-| Daily use | Needs escalation | 
-</WRAP> 
- 
-Frequent rescue inhaler use is a marker of worsening airway inflammation — not a need for more bronchodilator. 
- 
----- 
- 
-===== Adverse Effects ===== 
- 
-^ Effect ^ Mechanism ^ 
-| Tremor | Skeletal muscle β2 stimulation | 
-| Tachycardia | β1 spillover | 
-| Hypokalemia | Intracellular potassium shift | 
-| Anxiety | Adrenergic stimulation | 
- 
-Dose dependent. 
- 
----- 
- 
-===== Clinical Pearls ===== 
- 
-<WRAP round tip 90%> 
-The rescue inhaler measures disease control. 
- 
-More SABA = more inflammation 
-</WRAP> 
- 
-  * First drug used in asthma exacerbation 
-  * Spacer improves delivery significantly 
-  * Nebulizer is easier, not stronger 
-  * Overuse predicts hospitalization risk 
- 
----- 
- 
-===== Comparison Within β2 Class ===== 
- 
-^ Class ^ Role ^ Duration ^ 
-| [[respiratory:beta2_agonists:saba|SABA]] | Rescue | 4–6 hr | 
-| [[respiratory:beta2_agonists:laba|LABA]] | Maintenance | 12–24 hr | 
- 
----- 
- 
-===== Related ===== 
- 
-  * [[respiratory:beta2_agonists:start|β2 Agonists]] 
-  * [[respiratory:inhaled_corticosteroids:start|Inhaled Corticosteroids]] 
-  * [[respiratory:asthma|Asthma]] 
-  * [[respiratory:copd|COPD]] 
respiratory/beta2_agonists/start.1771167857.txt.gz · Last modified: by andrew2393cns